A therapeutic regimen of ceftazidime-avibactam for a critical patient receiving prolonged intermittent renal replacement therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A therapeutic regimen of ceftazidime-avibactam for a critical patient receiving prolonged intermittent renal replacement therapy

Published:2023-06 Issue:6 Volume:29 Page:620-623
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Yan Yu-ying,Jin Yi,Cao Xiang-yuan,Chen Song-yu,Liu Wen-hao,Shen Chen-Rui,Qiu Yu-shuang,Shen Fu-ming,Ni Min^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference13 articles.

1. In vitro susceptibility of characterized beta-lactamase-producing strains tested with avibactam combinations;Li;Antimicrob Agents Chemother,2015

2. Safety profile of ceftazidime-avibactam: pooled data from the adult phase II and phase III clinical trial programme;Cheng;Drug Saf,2020

3. Phase I study assessing the safety, tolerability, and pharmacokinetics of avibactam and ceftazidime-avibactam in healthy Japanese volunteers;Tominaga;J Infect Chemother,2015

4. Pharmacokinetics and dialytic clearance of ceftazidime-avibactam in a critically ill patient on continuous venovenous hemofiltration;Wenzler;Antimicrob Agents Chemother,2017

5. Steady-state ceftazidime-avibactam serum concentrations and dosing recommendations in a critically ill patient being treated for Pseudomonas aeruginosa pneumonia and undergoing continuous venovenous hemodiafiltration;Soukup;Pharmacotherapy,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP